Equities analysts expect AmerisourceBergen Corp. (NYSE:ABC) to announce earnings of $1.37 per share for the current fiscal quarter, Zacks Investment Research reports. Six analysts have made estimates for AmerisourceBergen Corp.’s earnings. The highest EPS estimate is $1.41 and the lowest is $1.35. AmerisourceBergen Corp. also reported earnings of $1.37 per share in the same quarter last year. The company is expected to issue its next earnings report on Tuesday, August 1st.

On average, analysts expect that AmerisourceBergen Corp. will report full year earnings of $5.86 per share for the current fiscal year, with EPS estimates ranging from $5.84 to $5.90. For the next fiscal year, analysts anticipate that the company will report earnings of $6.35 per share, with EPS estimates ranging from $6.20 to $6.52. Zacks Investment Research’s EPS calculations are a mean average based on a survey of sell-side research firms that cover AmerisourceBergen Corp..

AmerisourceBergen Corp. (NYSE:ABC) last released its earnings results on Thursday, May 4th. The company reported $1.77 EPS for the quarter, topping analysts’ consensus estimates of $1.68 by $0.09. The business had revenue of $37.15 billion during the quarter, compared to analysts’ expectations of $38.07 billion. AmerisourceBergen Corp. had a net margin of 0.91% and a return on equity of 62.44%. The company’s quarterly revenue was up 4.1% on a year-over-year basis. During the same quarter in the previous year, the company earned $1.68 earnings per share.

A number of equities research analysts recently issued reports on ABC shares. Vetr upgraded shares of AmerisourceBergen Corp. from a “hold” rating to a “buy” rating and set a $94.25 target price for the company in a report on Monday, February 20th. Needham & Company LLC started coverage on shares of AmerisourceBergen Corp. in a report on Tuesday, April 4th. They issued a “buy” rating and a $99.00 target price for the company. Jefferies Group LLC started coverage on shares of AmerisourceBergen Corp. in a report on Wednesday, May 17th. They issued a “hold” rating and a $95.00 target price for the company. Credit Suisse Group AG restated a “buy” rating on shares of AmerisourceBergen Corp. in a report on Sunday, February 5th. Finally, Morgan Stanley upgraded shares of AmerisourceBergen Corp. from an “equal weight” rating to an “overweight” rating in a report on Tuesday, January 31st. Eight research analysts have rated the stock with a hold rating, nine have assigned a buy rating and one has issued a strong buy rating to the company. The stock currently has a consensus rating of “Buy” and a consensus price target of $94.00.

TRADEMARK VIOLATION WARNING: This piece was published by American Banking News and is the sole property of of American Banking News. If you are reading this piece on another publication, it was illegally copied and republished in violation of United States and international trademark & copyright laws. The legal version of this piece can be accessed at https://www.americanbankingnews.com/2017/05/25/1-37-earnings-per-share-expected-for-amerisourcebergen-corp-abc-this-quarter.html.

AmerisourceBergen Corp. (NYSE:ABC) traded up 1.27% during mid-day trading on Thursday, hitting $91.11. 1,076,737 shares of the stock were exchanged. The company has a market cap of $19.89 billion, a P/E ratio of 17.68 and a beta of 0.82. The company has a 50-day moving average price of $85.85 and a 200-day moving average price of $84.63. AmerisourceBergen Corp. has a one year low of $68.38 and a one year high of $94.50.

The company also recently announced a quarterly dividend, which will be paid on Monday, June 5th. Investors of record on Monday, May 22nd will be given a $0.365 dividend. The ex-dividend date is Thursday, May 18th. This represents a $1.46 annualized dividend and a yield of 1.62%. AmerisourceBergen Corp.’s dividend payout ratio (DPR) is currently 24.37%.

In other AmerisourceBergen Corp. news, insider Gina Clark sold 12,000 shares of AmerisourceBergen Corp. stock in a transaction on Monday, March 13th. The stock was sold at an average price of $89.03, for a total transaction of $1,068,360.00. Following the completion of the transaction, the insider now directly owns 12,103 shares of the company’s stock, valued at $1,077,530.09. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Chairman Steven H. Collis sold 15,000 shares of AmerisourceBergen Corp. stock in a transaction on Monday, May 1st. The shares were sold at an average price of $81.98, for a total value of $1,229,700.00. Following the transaction, the chairman now directly owns 253,876 shares of the company’s stock, valued at $20,812,754.48. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 51,958 shares of company stock valued at $4,537,753. 27.40% of the stock is owned by company insiders.

Several hedge funds and other institutional investors have recently modified their holdings of the stock. Point72 Asia Hong Kong Ltd bought a new position in shares of AmerisourceBergen Corp. during the first quarter worth about $105,000. American Beacon Advisors Inc. bought a new position in shares of AmerisourceBergen Corp. during the first quarter worth about $108,000. SRS Capital Advisors Inc. boosted its position in shares of AmerisourceBergen Corp. by 0.3% in the first quarter. SRS Capital Advisors Inc. now owns 1,235 shares of the company’s stock worth $109,000 after buying an additional 4 shares during the last quarter. Apriem Advisors boosted its position in shares of AmerisourceBergen Corp. by 460.0% in the third quarter. Apriem Advisors now owns 1,400 shares of the company’s stock worth $113,000 after buying an additional 1,150 shares during the last quarter. Finally, Archford Capital Strategies LLC bought a new position in shares of AmerisourceBergen Corp. during the fourth quarter worth about $125,000. 69.11% of the stock is owned by institutional investors.

AmerisourceBergen Corp. Company Profile

AmerisourceBergen Corporation is a pharmaceutical sourcing and distribution services company. The Company’s segments include Pharmaceutical Distribution and Other. The Company provides services to healthcare providers, and pharmaceutical and biotech manufacturers. As of June 30, 2016, the Pharmaceutical Distribution segment consists of two operating segments, including the operations of AmerisourceBergen Drug Corporation (ABDC) and AmerisourceBergen Specialty Group (ABSG), which distributes specialty drugs to their customers.

12 Month Chart for NYSE:ABC

Get a free copy of the Zacks research report on AmerisourceBergen Corp. (ABC)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for AmerisourceBergen Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AmerisourceBergen Corp. and related companies with MarketBeat.com's FREE daily email newsletter.